Clinical trial
IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors
NCT00591292 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors
- Lead sponsor
- Alaunos Therapeutics
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 2, 2007
- Completion date
- March 10, 2009
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors